Cargando…
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes
Type 1 diabetes (T1D) is a chronic metabolic disease characterized by the autoimmune destruction of β-cells in the pancreatic islets. T1D is preceded by islet-specific inflammation led by several immune cells. Among them, natural killer (NK) cells are emerging as important players in T1D development...
Autores principales: | Gomez-Muñoz, Laia, Perna-Barrull, David, Villalba, Adrian, Rodriguez-Fernandez, Silvia, Ampudia, Rosa-Maria, Teniente-Serra, Aina, Vazquez, Federico, Murillo, Marta, Perez, Jacobo, Corripio, Raquel, Bel, Joan, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869615/ https://www.ncbi.nlm.nih.gov/pubmed/33569058 http://dx.doi.org/10.3389/fimmu.2020.611522 |
Ejemplares similares
-
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
por: Gomez-Muñoz, Laia, et al.
Publicado: (2022) -
Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion
por: Gomez-Muñoz, Laia, et al.
Publicado: (2023) -
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2019) -
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020)